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ment was rapid. Median time to achieve an absolute neutrophil
count 	500 cells/L was post-transplant day (D) 9 (range,
8–11). Full donor lymphoid chimerism (95% by VNTR-PCR on
CD3 sorted peripheral blood) was achieved in all pts (18/21 D 
14; 21/21 D  28). Immune recovery was brisk and sustained.
CD4, CD8, and NK cell numbers exceeded those at study entry by
D  28. Serum IL-7 levels were inversely correlated with CD4
counts. B-cell counts approached entry values by D  100. Sub-
stantial numbers of naive (CD45RA/CD62L) CD4 and
CD8 T cells were detected on D  28, suggestive of early
recovery of thymic function. Conclusions: Targeted pre-trans-
plant immune depletion and NMSCT results in rapid, sustained
donor-derived engraftment and immune reconstitution in pediatric
pts with malignancy. Early immune recovery includes naive T cell
subsets and B cells. Despite potential obstacles in pediatric pts,
NMSCT conditioning can induce rapid engraftment and immue
reconstitution, which may allow application of this novel platform
to direct allogeneic anti-tumor immune responses in high-risk
childhood cancers (Table 1).
Table 1. Immune Depletion and Recovery (Mean Cell Counts/L)
Pre Post D  0 D  28 D  60 D  100 D  180
CD4 304 156 27 394 376 313 413
CD8 344 226 4 561 684 635 544
Naive CD4 69 35 20 123 64 100 118
Naive CD8 130 49 87 192 137 206 169
B cell 115 3 4 12 94 106 200
NK cell 87 111 1 274 222 154 130
Data represent mean cell counts/L; Pre: entry; Post: after induc-
tion; D: post-transplant day.
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Post-transplant T cell deﬁciency (especially in adults) is related to
impaired thymus-dependent lymphopoiesis. However, others and
we have previously found in human and murine studies that pe-
ripheral T cell apoptosis is increased in recipients of an allogeneic
bone marrow transplantation (allo BMT). We used murine BMT
models to further analyze peripheral T cell apoptosis in recipients
of a T cell-depleted (TCD) or T cell-replete BMT. In recipients of
a TCD BMT, we found that donor derived T cells had a high
percentage of apoptotic cells (Annexin-V) in both syngeneic and
allogeneic hosts when analyzed at days 14 and 28 after BMT.
Cleaved caspase-3 levels in these T cells were also increased in
comparison with non-transplanted controls. Both CD4 and
CD8 memory (CD44hi) T cells had a higher percentage of
apoptotic cells compared to naive (CD44lo) cells. This was asso-
ciated with decreased levels of intracellular Bcl-2 in de novo gen-
erated T cells from both young and old recipients of an allo
TCD-BMT. We then transplanted allogeneic hosts with bone
marrow (BM) from RAG-2-eGFP transgenic mice to examine
apoptosis in newly generated T cells (recent thymic emigrants
[RTE]) and found increased apoptotic cells in both eGFPhi and
eGFPlo T cells. This demonstrates that both non-divided (eGF-
Phi) and proliferating (eGFPlo) donor BM derived T cells can
undergo apoptosis in the periphery after TCD-BMT. In recipients
with GVHD, we observed a severe loss of thymic cellularity and
low numbers of BM derived de novo generated T cells with a high
fraction of apoptotic cells. These had very low Bcl-2 expression and
increased caspase 8 and 9 activation. Conversely, alloreactive T
cells (from the mature donor T cells in the allograft) showed
upregulation of Fas expression, higher Bcl-2 levels, less caspase
activity, and contained lower numbers of apoptotic T cells com-
pared to BM derived T cells. Allogeneic recipients receiving donor
BM deﬁcient for Fas, Fas Ligand and TRAIL, or over-expressing
Bcl-2 and Akt had no decrease in donor derived apoptotic T cells,
suggesting that these molecules were not absolutely required for
post-transplant peripheral T cell apoptosis. We conclude that
newly generated donor BM derived T cells have increased periph-
eral T cell apoptosis, especially in older recipients and in recipients
with GVHD, which could be an important factor in the delay of
post-transplant T cell reconstitution.
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Aim of the study: We assessed the impact of CD8-depletion
(performed in an effort to reduce the incidence of acute GVHD)
on immune reconstitution after peripheral blood stem cell trans-
plantation (PBSCT) with nonmyeloablative conditioning consist-
ing of 2 Gy TBI with (n  39) or without (n  11) ﬂudarabine.
Patients and methods: 50 patients were randomised between
CD8-depletion (n  22) and lack of any manipulation (n  28).
Median patient age was 57 (range 36–69) years. Twenty patients
received grafts from HLA-matched related donors and 30 from
unrelated donors. CD8-depletion was performed with the Eligix
system. GvHD prophylaxis consisted of mycophenomate mofetil
(MMF) and cyclosporine (CSP). The different peripheral blood
subpopulations were analyzed by 3-color ﬂow-cytometry on days
28, 40, 60, 80, 100, 120, 180, and 365 after PBSCT. The diversity
of the Vb repertoire in CD4 and CD8 T cells was assessed by
rt-PCR on day 180 after PBSCT. Thymic output was determined
through analyses of sjTRECS by quantitative PCR on days 100 and
365 after PBSCT. The expression of transcription factor Foxp3
was measured by quantitative RT-PCR on days 100 and 365 after
PBSCT in order to assess regulatory T cells population. The
impact of PBSC manipulation on T cell subsets recovery was
analyzed by the Mann-Whitney rank sum test. Results: The me-
dian number of CD34, CD3, CD4, and CD8 cells 
106/kg infused were 4.1, 315, 185, and 131 in the unmanipulated
group versus 3.7 (NS), 110 (P  .001), 94 (P  .002), and 4 (P 
.001) in the CD8-depleted group, respectively.CD8 depletion sig-
niﬁcantly impaired recovery of CD3CD8 T cells on days 100,
120, and 180 after HCT (P  .02, P  .02 and P  .03, respec-
tively), but not those of CD3 T cells, CD3CD4 T cells,
CD45RA T cells, CD19B-cells, or CD56NK cells. CD3T
cell chimerism levels from day 28 to day 80 were also signiﬁcantly
decreased in the CD8-depleted group. The levels of sjTRECS
after HCT correlated with those of CD3CD4CD45RA T
cells (Spearman R  0.41, P  .0034).The diversity of VB reper-
toire among CD4 and CD8 T cells on day 180 was similar
among the 2 groups, as were the sjTRECS and Foxp3 levels.
Conclusions: CD8-depletion of PBSC decreased T cell chimer-
ism levels and recovery of CD8 T cells, but did not affect
recovery of other cell subsets, thymic output, nor Vb repertoire
diversity, suggesting that immune reconstitution the ﬁrst year after
HCT was mainly driven by expansion of mature T cells contained
in the graft.
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